Takeda Pharmaceutical Company on Thursday, June 6, lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals in a lawsuit accusing Takeda of an antitrust violation.
Affirming a magistrate judge, US District Judge Freda Wolfson in Trenton, New Jersey, rejected Takeda’s argument that it had an implied attorney-client relationship with Baker Botts because of the firm’s previous representation of Takeda’s co-plaintiff in related patent litigation.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
